Ing Investment Management »

Celldex Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $824k 20k 41.97
2023-09-30 $512k 19k 27.52
2023-06-30 $624k 18k 33.93
2023-03-31 $629k 18k 35.98
2022-12-31 $786k 18k 44.57
2022-09-30 $496k 18k 28.13
2022-06-30 $475k 18k 26.94
2022-03-31 $612k 18k 34.05
2021-12-31 $695k 18k 38.66
2021-09-30 $963k 18k 54.01
2021-06-30 $516k 15k 33.42